-
Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves
Wednesday, July 19, 2023 - 9:40am | 715Read More...Shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) jumped nearly 25% on Friday after the San Diego-based company announced preliminary second-quarter results and a pivotal acquisition. The gain was the biggest among all mid- and large cap stocks on the day and more than double that of the...
-
Biogen And Gilead Sciences Buck Biotech Short Interest Trend
Sunday, June 12, 2016 - 2:35pm | 588Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of both of these stocks rose sharply during the two-week period. Short sellers shied away from many of the...
-
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Friday, May 13, 2016 - 1:26pm | 550Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of one of those two stocks slumped more than 22 percent during the period. Short sellers shied away from many of...
-
Short Sellers Dump Amgen And Baxalta
Friday, May 13, 2016 - 8:56am | 539Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out as leaders of that trend in those two weeks. Shares of one of those two stocks rose while the other slumped during the period. Short sellers moved on only a few of the leading...
-
Acadia Continues Huge Rise Following FDA Panel Vote
Wednesday, March 30, 2016 - 7:52am | 177Read More...Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) were trading higher by more than 22 percent early Wednesday morning. A U.S. Food and Drug Administration panel voted 12-2 on Tuesday that Acadia's drug pimavanserin, a treatment for psychosis associated with Parkinson's disease,...
-
Acadia Pharmaceuticals Are Spiking
Monday, February 1, 2016 - 9:55am | 217Read More...Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) were trading higher by nearly 9 percent early Monday morning. Acadia Pharmaceuticals announced after Friday's market close that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration will review data...
-
Wild Short Interest Swings For These Three Biotech Stocks
Monday, October 12, 2015 - 3:17pm | 882Read More...Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...
-
Acadia Pharma May No Longer Be A Buy Ahead Of NDA Filing
Friday, August 7, 2015 - 1:27pm | 277Read More...Piper Jaffray analyst Charles Duncan downgraded ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) from Overweight to Neutral, noting that the "next steps may be more challenging." At the same time, the analyst updated his price target to $48 from $39 prior. Duncan said that he is also...
-
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Thursday, July 3, 2014 - 10:36am | 873Read More...Cowen analysts recently released a research report that focused on biotech stocks with promising Phase 3 data leading into the U.S. Food and Drug Administration (FDA) approval process. ACADIA Pharmaceuticals (NASDAQ: ACAD), Alexion Pharmaceuticals (NASDAQ: ALXN), InterMune (NASDAQ: ITMN) and...
-
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
Saturday, May 18, 2013 - 3:54pm | 968Read More...Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who...
-
Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)
Saturday, March 23, 2013 - 11:33am | 835Read More...Some smaller health care companies saw unusual movement in their stocks on Friday. And not just in Anacor Pharmaceuticals (NASDAQ: ANAC), Halozyme Therapeutics (NASDAQ: HALO), Puma Biotechnology (NYSE: PBYI) and Questcor Pharmaceuticals (NASDAQ: QCOR), which are discussed below. But also ACADIA...
